Literature DB >> 10470697

Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years.

R T Stein1, D Sherrill, W J Morgan, C J Holberg, M Halonen, L M Taussig, A L Wright, F D Martinez.   

Abstract

BACKGROUND: The relation between lower respiratory tract illnesses in early life caused by the respiratory syncytial virus (RSV) and the subsequent development of wheezing and atopy in childhood is not well understood. We studied this relation in children who had lower respiratory tract illnesses that occurred before 3 years of age.
METHODS: Children were enrolled at birth and cases of lower respiratory tract illness were ascertained by a physician. Viral tests were done for specimens collected at the time of the illness. Children were classified into five groups according to type and cause of lower respiratory tract illness. Children were then followed prospectively up to age 13, and we measured frequency of wheezing, pulmonary function, and atopic status (allergy skin-prick tests, serum IgE concentrations).
FINDINGS: RSV lower respiratory tract illnesses were associated with an increased risk of infrequent wheeze (odds ratio 3.2 [95% CI 2.0-5.0], p < 0.001), and an increased risk of frequent wheeze (4.3 [2.2-8.7], p < or = 0.001) by age 6. Risk decreased markedly with age and was not significant by age 13. There was no association between RSV lower respiratory tract illnesses and subsequent atopic status. RSV lower respiratory tract illnesses were associated with significantly lower measurements of forced expiratory volume (2.11 [2.05-2.15], p < or = 0.001) when compared with those of children with no lower respiratory tract illnesses, but there was no difference in forced expiratory volume after inhalation of salbutamol.
INTERPRETATION: RSV lower respiratory tract illnesses in early childhood are an independent risk factor for the subsequent development of wheezing up to age 11 years but not at age 13. This association is not caused by an increased risk of allergic sensitisation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10470697     DOI: 10.1016/S0140-6736(98)10321-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  419 in total

1.  Introduction

Authors: 
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

Review 2.  Paediatric origins of adult lung disease.

Authors:  E von Mutius
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

3.  Asthma and early childhood infectious disease. Infection is trigger rather than cause.

Authors:  V Angelakou; M Bitsori; E Galanakis
Journal:  BMJ       Date:  2001-07-21

Review 4.  Allergen exposure and the development of asthma.

Authors:  R Sporik; T A Platts-Mills
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

5.  Airway function at one year: association with premorbid airway function, wheezing, and maternal smoking.

Authors:  C Dezateux; J Stocks; A M Wade; I Dundas; M E Fletcher
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

Review 6.  Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma.

Authors:  Amy S Feldman; Yuan He; Martin L Moore; Marc B Hershenson; Tina V Hartert
Journal:  Am J Respir Crit Care Med       Date:  2015-01-01       Impact factor: 21.405

Review 7.  The burden of childhood asthma.

Authors:  E von Mutius
Journal:  Arch Dis Child       Date:  2000-06       Impact factor: 3.791

8.  Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study.

Authors:  Debra A Stern; Wayne J Morgan; Anne L Wright; Stefano Guerra; Fernando D Martinez
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

Review 9.  The role of early life viral bronchiolitis in the inception of asthma.

Authors:  Avraham Beigelman; Leonard B Bacharier
Journal:  Curr Opin Allergy Clin Immunol       Date:  2013-04

10.  Respiratory virus-induced regulation of asthma-like responses in mice depends upon CD8 T cells and interferon-gamma production.

Authors:  Joost J Smit; Louis Boon; Nicholas W Lukacs
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.